Cargando…

Perspective: Treatment for Disease Modification in Chronic Neurodegeneration

Symptomatic treatments are available for Parkinson’s disease and Alzheimer’s disease. An unmet need is cure or disease modification. This review discusses possible reasons for negative clinical study outcomes on disease modification following promising positive findings from experimental research. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller, Thomas, Mueller, Bernhard Klaus, Riederer, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069143/ https://www.ncbi.nlm.nih.gov/pubmed/33921342 http://dx.doi.org/10.3390/cells10040873

Ejemplares similares

Epigenetic modifications of chronic hypoxia-mediated neurodegeneration in Alzheimer’s disease
por: Liu, Hui, et al.
Publicado: (2014)

Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics
por: Gerlach, Manfred, et al.
Publicado: (2011)

Perspective: Is a Closer Interaction between Experimental and Clinical Research Paradigms in Chronic Neurodegeneration, Such as Parkinson’s Disease, Necessary Again?
por: Müller, Thomas
Publicado: (2022)

Proteomics of protein post-translational modifications implicated in neurodegeneration
por: Ren, Ru-Jing, et al.
Publicado: (2014)

Emerging Roles of N6-Methyladenosine Modification in Neurodevelopment and Neurodegeneration
por: Shu, Liqi, et al.
Publicado: (2021)

Insights into Mechanisms of Chronic Neurodegeneration
por: Diack, Abigail B., et al.
Publicado: (2016)

Roles of Elongator Dependent tRNA Modification Pathways in Neurodegeneration and Cancer
por: Hawer, Harmen, et al.
Publicado: (2018)

Mitochondrial Targeting in Neurodegeneration: A Heme Perspective
por: Fiorito, Veronica, et al.
Publicado: (2018)

Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling
por: Adav, Sunil S., et al.
Publicado: (2016)

Gut Microbiota in Autophagy Regulation: New Therapeutic Perspective in Neurodegeneration
por: Mitra, Sarmistha, et al.
Publicado: (2023)

Melatonin: Clinical Perspectives in Neurodegeneration
por: Cardinali, Daniel P.
Publicado: (2019)

Kynurenines, neurodegeneration and Alzheimer’s disease
por: Kincses, Zsigmond Tamas, et al.
Publicado: (2010)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease
por: Petrillo, Francesco, et al.
Publicado: (2021)

Cyclooxygenase and Neuroinflammation in Parkinson’s Disease Neurodegeneration
por: Bartels, Anna L, et al.
Publicado: (2010)

MAO-inhibitors in Parkinson's Disease
por: Riederer, Peter, et al.
Publicado: (2011)

Alzheimer’s disease risk after COVID-19: a view from the perspective of the infectious hypothesis of neurodegeneration
por: Olivera, Eugenia, et al.
Publicado: (2022)

Oral frailty and neurodegeneration in Alzheimer’s disease
por: Dibello, Vittorio, et al.
Publicado: (2021)

Lysosomal Storage Diseases—Regulating Neurodegeneration
por: Onyenwoke, Rob U., et al.
Publicado: (2016)

Cerebellar pathology in motor neuron disease: neuroplasticity and neurodegeneration
por: Chipika, Rangariroyashe H., et al.
Publicado: (2022)

Chronic Stress and Glucocorticoids: From Neuronal Plasticity to Neurodegeneration
por: Vyas, Sheela, et al.
Publicado: (2016)

Solving neurodegeneration: common mechanisms and strategies for new treatments
por: Wareham, Lauren K., et al.
Publicado: (2022)

Understanding Neurodegeneration from a Clinical and Therapeutic Perspective in Early Diabetic Retinopathy
por: Fragiotta, Serena, et al.
Publicado: (2022)

Chronic Rhinosinusitis and Alzheimer’s Disease—A Possible Role for the Nasal Microbiome in Causing Neurodegeneration in the Elderly
por: Harrass, Sanaa, et al.
Publicado: (2021)

Protein homeostasis and aging in neurodegeneration
por: Douglas, Peter M., et al.
Publicado: (2010)

Inflammation and neurodegeneration: chronicity matters
por: Walker, Keenan A.
Publicado: (2018)

Disruption of axonal transport in neurodegeneration
por: Berth, Sarah H., et al.
Publicado: (2023)

Tau-mediated Neurodegeneration and Potential Implications in Diagnosis and Treatment of Alzheimer's Disease
por: Wu, Xi-Lin, et al.
Publicado: (2017)

Viruses and neurodegeneration
por: Zhou, Li, et al.
Publicado: (2013)

Metals and Neurodegeneration
por: Chen, Pan, et al.
Publicado: (2016)

Deubiquitinases in Neurodegeneration
por: Bello, Abudu I., et al.
Publicado: (2022)

Mitochondrial Neurodegeneration
por: Zeviani, Massimo, et al.
Publicado: (2022)

Neurodegeneration in Hepatic and Neurologic Wilson’s Disease
por: Viveiros, André, et al.
Publicado: (2021)

Racemization in Post-Translational Modifications Relevance to Protein Aging, Aggregation and Neurodegeneration: Tip of the Iceberg
por: Dyakin, Victor V., et al.
Publicado: (2021)

The Role of Inflammation in Retinal Neurodegeneration and Degenerative Diseases
por: Kaur, Geetika, et al.
Publicado: (2021)

Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
por: Gelders, Géraldine, et al.
Publicado: (2018)

Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease
por: Marogianni, Chrysoula, et al.
Publicado: (2020)

Classification of advanced stages of Parkinson’s disease: translation into stratified treatments
por: Krüger, Rejko, et al.
Publicado: (2017)

Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration
por: Andersen, Hjalte Holm, et al.
Publicado: (2013)

Loss of Chondroitin Sulfate Modification Causes Inflammation and Neurodegeneration in skt Mice
por: Macke, Erica L., et al.
Publicado: (2020)

The Nigral Coup in Parkinson’s Disease by α-Synuclein and Its Associated Rebels
por: Sian-Hulsmann, Jeswinder, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kp1na0sj1229ac915g0g089fo6